Tolerability and Acceptability of Electroporation During a Phase 1 Vaccine Trial at Two Sites in Uganda and Rwanda

Retrovirology - United Kingdom
doi 10.1186/1742-4690-9-s2-p126
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Electroporation (EP)-related Technical Errors Experienced During an HIV Vaccine Clinical Trial Conducted in Rwanda and Uganda: Lessons Learned

Retrovirology
VirologyInfectious Diseases
2012English

Uptake and Tolerability of Repeated Mucosal Specimen Collection in Two Phase 1 AIDS Preventive Vaccine Trials in Kenya

Retrovirology
VirologyInfectious Diseases
2012English

Pediatric HIV Type 1 Vaccine Trial Acceptability Among Mothers in Kenya

AIDS Research and Human Retroviruses
VirologyInfectious DiseasesImmunology
2006English

Safety, Tolerability, and Pharmacokinetics of Adrenomedullin in Healthy Males: A Randomized, Double-Blind, Phase 1 Clinical Trial

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2020English

Industries Without Smokestacks in Uganda and Rwanda

WIDER Working Paper
2017English

Safety and Immunogenicity of a mRNA-based Chikungunya Vaccine in a Phase 1 Dose-Ranging Trial

International Journal of Infectious Diseases
MedicineInfectious DiseasesMicrobiology
2019English

Assessing the Feasibility, Acceptability, and Costs of Diagnosing HIV at Birth in Lesotho and Rwanda

2018English

Safety and Acceptability of Clozapine and Risperidone in Progressive Multiple Sclerosis: A Phase 1, Randomized, Blinded, Placebo-Controlled Trial

2020English

A Phase 1 Trial to Assess the Safety, Acceptability, Pharmacokinetics, and Pharmacodynamics of a Novel Dapivirine Vaginal Film

Journal of Acquired Immune Deficiency Syndromes
Infectious DiseasesPharmacology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy